Remission of acromegaly following long-term therapy with cabergoline: Report of two cases

Pituitary

Volumn 11, Issue 1, 2008, Pages 103-107

  Verhelst, Johan A ^a   Abrams, Pascale J ^b   Abs, Roger ^b  

^a ZNA Middelheim ^*  (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Acromegaly; Cabergoline; Dopamine agonist; IGF I; Therapy

Indexed keywords

CABERGOLINE; GROWTH HORMONE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; ARTICLE; CASE REPORT; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HEARING IMPAIRMENT; HUMAN; HYPOPHYSIS ADENOMA; LIBIDO DISORDER; LONG TERM CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; REMISSION; SLEEP DISORDER; STOMACH PAIN; SWEATING; TINNITUS; TREATMENT RESPONSE;

ABDOMINAL PAIN; ACROMEGALY; ADULT; BIOLOGICAL MARKERS; DOPAMINE AGONISTS; DRUG ADMINISTRATION SCHEDULE; ERGOLINES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIBIDO; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 38649113922     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0041-y     Document Type: Article

References (28)

1. Bates AS, Van't Hoff W, Jones JM, Clayton RN (1993) An audit of outcome of treatment in acromegaly. Q J Med 86:293-299
2. Melmed S (2006) Medical progress: Acromegaly. N Engl J Med 355:2558-2573
3. Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Tamburrano G, Cantore G (2003) Evolving criteria for post-operative biochemical remission of acromegaly: Can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature. Endocr Relat Cancer 10:611-619
4. Monson JP (2006) Is there still a role for radiotherapy in acromegaly? Neuroendocrinology 83:269-273
5. Abs R, Verhelst J, Maiter D, Van Acker K, Nobels F, Coolens JL, Mahler C, Beckers A (1998) Cabergoline in the treatment of acromegaly: A study in 64 patients. J Clin Endocrinol Metab 83:374-378
6. Flogstad AK, Halse J, Bakke S, Lancranjan I, Marbach P, Bruns C, Jervell J (1997) Sandostatin LAR in acromegalic patients: Long term treatment. J Clin Endocrinol Metab 82:23-28
7. Verhelst JA, Pedroncelli AM, Abs R, Montini M, Vandeweghe MV, Albani G, Maiter D, Pagani MD, Legros JJ, Gianola D, Bex M, Poppe K, Mockel J, Pagani G (2000) Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients. Eur J Endocrinol 143:577-584
8. Alexopoulou O, Abrams P, Verhelst J, Poppe K, Velkeniers B, Abs R, Maiter D (2004) Efficacy and tolerability of lanreotide Autogel therapy in acromegalic patients previously treated with octreotide LAR. Eur J Endocrinol 151:317-324
9. Trainer PJ, Drake WM, Katznelson L et al (2000) Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 342:1171-1177
10. Jaffe CA, Barkan AL (1992) Treatment of acromegaly with dopamine agonists. Endocrinol Metab Clin North Am 121:713-735
11. Colao A, Ferone D, Marzullo P, Di Sarno A, Cerbone G, Sarnacchiaro F, Cirillo S, Merola B, Lombardi G (1997) Effect of different dopaminergic agents in the treatment of acromegaly. J Clin Endocrinol Metab 82:518-523
12. Verhelst J, Abs R (2003) Hyperprolactinemia: Pathophysiology and management. Treat Endocrinol 2:23-32
13. Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhoea. N Engl J Med 331:904-909
14. Biller BMK, Molitch ME, Vance ML, Cannistraro KB, Davis KR, Simons JA, Schoenfelder JR, Klibanski A (1996) Treatment of prolactin-secreting macroadenoma with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab 81:2338-2343
15. Verhelst J, Abs R, Maiter D, van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A (1999) Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients. J Clin Endocrinol Metab 84:2518-2522
16. Ferrari C, Paracchi A, Romano C, Gerevini G, Boghen M, Barreca A, Fortini P,Dubini A (1988) Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients. Clin Endocrinol (Oxf) 29:467-476
17. Jackson SNJ, Fowler J, Howlett TA (1997) Cabergoline treatment of acromegaly: A preliminary dose finding study. Clin Endocrinol (Oxf) 46:745-749
18. Cozzi R, Attanasio R, Lodrini S, Lasio G (2004) Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: Efficacy and lack of predictive value of prolactin status. Clin Endocrinol (Oxf) 61:209-215
19. Selvarajah D, Webster J, Ross R, Newell-Price J (2005) Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly. Eur J Endocrinol 152:569-574
20. Gatta B, Hau DH, Catargi B, Roger P, Tabarin A (2005) Re-evaluation of the efficacy of the association of cabergoline to somatostatin analogues in acromegalic patients. Clin Endocrinol (Oxf) 63:477-478
21. Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R, Lombardi G (2003) Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 349:2023-2033
22. Muratori M, Arosio M, Gambino G, Romano C, Biella O, Faglia G (1997) Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients. J Endocrinol Invest 20:537-546
23. Biswas M, Smith J, Jadon D, McEwan P, Rees DA, Evans LM, Scanlon MF, Davies JS (2005) Long-term remission following withdrawal of dopamine agonist therapy in subject with microprolactinomas. Clin Endocrinol (Oxf) 63:26-31
24. Nishioka H, Haraoka J, Miki T (2005) Spontaneous remission of functioning pituitary adenomas without hypopituitarism following infarctive apoplexy: Two case reports. Endocr J 52:117-123
25. Shirataki K, Chihara K, Shibata Y, Tamaki N, Matsumoto S, Fujita T (1988) Pituitary apoplexy manifested during a bromocriptine test in a patient with a growth hormone- and prolactin-producing pituitary adenoma. Neurosurgery 23:395-398
26. Alhajje A, Lambert M, Crabbe J (1985) Pituitary apoplexy in an acromegalic patient during bromocriptine therapy. Case report. J Neurosurg 63:288-292
27. Kontogeorgos G, Horvath E, Kovacs K, Coire C, Lloyd RV, Scheithauer BW, Smyth HS (2006) Morphologic changes of prolactin-producing pituitary adenomas after short treatment with dopamine agonists. Acta Neuropathol (Berl) 111:46-52
28. Stefaneanu L, Kovacs K, Scheithauer BW, Kontogeorgos G, Riehle DL, Sebo TJ, Murray D, Vidal S, Tran A, Buchfelder M, Fahlbusch R (2000) Effect of dopamine agonists on lactotroph adenomas of the human pituitary. Endocr Pathol 11:341-352